JP2014516540A - ２５−ヒドロキシビタミンｄ２およびｄ３に対する抗体ならびにその使用 - Google Patents

２５−ヒドロキシビタミンｄ２およびｄ３に対する抗体ならびにその使用 Download PDF

Info

Publication number
JP2014516540A
JP2014516540A JP2014512897A JP2014512897A JP2014516540A JP 2014516540 A JP2014516540 A JP 2014516540A JP 2014512897 A JP2014512897 A JP 2014512897A JP 2014512897 A JP2014512897 A JP 2014512897A JP 2014516540 A JP2014516540 A JP 2014516540A
Authority
JP
Japan
Prior art keywords
hydroxyvitamin
antibody
vitamin
seq
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014512897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014516540A5 (cg-RX-API-DMAC7.html
Inventor
キャンベル，ブルース・エー
リン，スペンサー・シャン−シ
リャオ，チム
サハキアン，ニヴァー・パノシアン
フリーマン，ジェームズ・ヴィンセント
エヴァンジェリスタ，ラモン・エイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Publication of JP2014516540A publication Critical patent/JP2014516540A/ja
Publication of JP2014516540A5 publication Critical patent/JP2014516540A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/02—Nutritional disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2014512897A 2011-05-20 2012-05-18 ２５−ヒドロキシビタミンｄ２およびｄ３に対する抗体ならびにその使用 Pending JP2014516540A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161488630P 2011-05-20 2011-05-20
US61/488,630 2011-05-20
US13/458,847 2012-04-27
US13/458,847 US8785603B2 (en) 2011-05-20 2012-04-27 Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof
PCT/US2012/038637 WO2012162165A2 (en) 2011-05-20 2012-05-18 Antibodies to 25-hydroxyvitamin d2 and d3 and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016191362A Division JP6404876B2 (ja) 2011-05-20 2016-09-29 ２５−ヒドロキシビタミンｄ２およびｄ３に対する抗体ならびにその使用

Publications (2)

Publication Number Publication Date
JP2014516540A true JP2014516540A (ja) 2014-07-17
JP2014516540A5 JP2014516540A5 (cg-RX-API-DMAC7.html) 2015-07-09

Family

ID=47217992

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014512897A Pending JP2014516540A (ja) 2011-05-20 2012-05-18 ２５−ヒドロキシビタミンｄ２およびｄ３に対する抗体ならびにその使用
JP2016191362A Active JP6404876B2 (ja) 2011-05-20 2016-09-29 ２５−ヒドロキシビタミンｄ２およびｄ３に対する抗体ならびにその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016191362A Active JP6404876B2 (ja) 2011-05-20 2016-09-29 ２５−ヒドロキシビタミンｄ２およびｄ３に対する抗体ならびにその使用

Country Status (8)

Country Link
US (6) US8785603B2 (cg-RX-API-DMAC7.html)
EP (1) EP2710376B1 (cg-RX-API-DMAC7.html)
JP (2) JP2014516540A (cg-RX-API-DMAC7.html)
KR (1) KR102032531B1 (cg-RX-API-DMAC7.html)
CN (1) CN103857698B (cg-RX-API-DMAC7.html)
AU (2) AU2012259080A1 (cg-RX-API-DMAC7.html)
ES (1) ES2710449T3 (cg-RX-API-DMAC7.html)
WO (1) WO2012162165A2 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022020884A (ja) * 2020-07-21 2022-02-02 株式会社ファンケル 血清ビタミンｄ代謝物の濃度の推定方法
JP2024535594A (ja) * 2021-10-13 2024-09-30 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド Ｄｈｅａｓアッセイ、そのための試薬、並びにその製造方法及び使用

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8785603B2 (en) * 2011-05-20 2014-07-22 Siemens Healthcare Diagnostics Inc. Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof
KR20220051197A (ko) 2012-05-17 2022-04-26 익스텐드 바이오사이언시즈, 인크. 개선된 약물 전달용 캐리어
CN103588872B (zh) * 2012-08-13 2016-01-06 北京博晖创新光电技术股份有限公司 一种维生素d合成抗原、其制备方法及应用
US9618523B2 (en) 2013-02-28 2017-04-11 Siemens Healthcare Diagnostics Inc. Methods and reagents for determining isomeric analytes
US20140273021A1 (en) * 2013-03-14 2014-09-18 Enzo Biochem, Inc. Vitamin d assays
US20140308751A1 (en) * 2013-04-12 2014-10-16 Siemens Healthcare Diagnostics Inc. Assays for Analyte Homologs
US20160178614A1 (en) * 2013-08-02 2016-06-23 Siemens Healthcare Diagnostics Inc. Cell-based control and method
EP3172239A4 (en) * 2014-06-27 2017-06-21 Siemens Healthcare Diagnostics Inc. Binding partners specific for vitamin d epimers
KR20170015527A (ko) * 2014-06-27 2017-02-08 지멘스 헬쓰케어 다이아그노스틱스 인크. 비타민 d 에피머에 대한 검정 방법
ES2853525T3 (es) * 2014-06-27 2021-09-16 Siemens Healthcare Diagnostics Inc Parejas de unión específicas para epímeros de vitamina D en ensayos de vitamina D
BR112016030507B1 (pt) 2014-06-27 2023-03-28 Siemens Healthcare Diagnostics Inc Compostos relacionados à vitamina d, e composição farmacêutica
CN104062440B (zh) * 2014-06-30 2016-05-11 韩雅君 一种快速检测维生素d的试纸条
CN104098493A (zh) * 2014-06-30 2014-10-15 湖南华腾制药有限公司 一种维生素d衍生物的制备方法
US10114030B2 (en) * 2014-07-10 2018-10-30 Shenzhen New Industries Biomedical Engineering Co., Ltd Detection agent for detecting 25-hydroxy vitamin D, preparation method and use
CN104076155B (zh) * 2014-07-10 2016-08-31 深圳市新产业生物医学工程股份有限公司 用于检测25-羟基维生素d的检测剂及制备方法和应用
WO2016065042A1 (en) 2014-10-22 2016-04-28 Extend Biosciences, Inc. Therapeutic vitamin d conjugates
US9789197B2 (en) 2014-10-22 2017-10-17 Extend Biosciences, Inc. RNAi vitamin D conjugates
WO2016065052A1 (en) 2014-10-22 2016-04-28 Extend Biosciences, Inc. Insulin vitamin d conjugates
KR20180104080A (ko) 2016-01-22 2018-09-19 아피메딕스, 인코포레이티드 비타민 d 대사산물 검출용 장치
US10338084B2 (en) 2016-04-07 2019-07-02 Quidel Corporation Processing reagent and use thereof in assays for detection of analytes associated with a binding protein
CN107325173A (zh) * 2016-04-28 2017-11-07 上海惠斯生物科技有限公司 一种25羟基维生素d3人工抗原、制备方法及应用
CN106199016A (zh) * 2016-06-30 2016-12-07 深圳市亚辉龙生物科技股份有限公司 25‑羟基维生素d化学发光免疫检测试剂盒及其制备方法
US20190309030A1 (en) * 2016-07-05 2019-10-10 Shenzhen Yhlo Biotech Co., Ltd. Acridine labelled conjugates and preparation methods therefor and chemiluminescent kits
WO2018006268A1 (zh) * 2016-07-05 2018-01-11 深圳市亚辉龙生物科技股份有限公司 吖啶标记结合物及其制备方法、化学发光试剂盒
CN106501535B (zh) * 2016-11-30 2018-11-09 迪瑞医疗科技股份有限公司 一种ans盐复合释放剂与检测血液中皮质醇的试剂盒
CN108205064B (zh) * 2018-03-28 2020-08-21 北京丹大生物技术有限公司 25ohd3检测试剂、试剂盒及其检测方法
CN108709993B (zh) * 2018-04-02 2021-03-26 深圳上泰生物工程有限公司 一种胶乳增强免疫比浊检测试剂盒及其制备和检测方法
WO2021030166A1 (en) * 2019-08-09 2021-02-18 Siemens Healthcare Diagnostics Inc. Anti-hog tcn1 monoclonal antibodies and methods of production and use thereof
CN110713533B (zh) * 2019-11-26 2021-03-16 杭州隆基生物技术有限公司 一种25-羟基维生素d3抗原及其制备方法
US20230115540A1 (en) * 2020-03-06 2023-04-13 H. Lee Moffitt Cancer Center And Research Institute, Inc. Tumor targeted fluorescence guidance for intraoperative margin assessment
CN111351945B (zh) * 2020-03-18 2021-04-23 东南大学 维生素d结合蛋白作为标志物在精神疾病抑郁症诊断中的应用
CN113999311B (zh) * 2020-07-28 2022-11-04 东莞市朋志生物科技有限公司 可特异性结合25-羟基维生素d的抗体、其应用以及诊断试剂盒
CN112624947B (zh) * 2021-01-25 2023-09-08 福建万菇生物科技有限公司 一种利用绣球菌子实体提取高含量维生素d2的方法
JP2025534350A (ja) 2022-09-30 2025-10-15 エクステンド バイオサイエンシズ インコーポレーテッド 長時間作用型副甲状腺ホルモン
CN119080938B (zh) * 2023-06-05 2025-06-24 东莞市朋志生物科技有限公司 抗25羟维生素d抗体、检测25羟维生素d的试剂和试剂盒
CN117417455B (zh) * 2023-10-30 2024-06-21 江南大学 一种特异性结合25-羟基维生素d3的抗原结合蛋白
CN120137045A (zh) * 2023-12-13 2025-06-13 菲鹏生物股份有限公司 抗25-羟基维生素d抗体及其用途
CN120025402A (zh) * 2025-02-20 2025-05-23 东南大学 一种靶向cldn6蛋白的多肽及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009509992A (ja) * 2005-09-29 2009-03-12 エフ．ホフマン−ラ ロシュ アーゲー ２５−ヒドロキシビタミンｄに対する抗体
US20110097733A1 (en) * 2009-10-27 2011-04-28 Michel Anciaux Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3267108D1 (en) 1982-04-20 1985-12-05 Teijin Ltd Novel vitamin d3 derivatives, processes for preparation thereof, and antigens comprising said derivatives to be used for preparation of antibodies for immunochemical assay and antibodies prepared therefrom
US4456553A (en) 1982-05-07 1984-06-26 Teijin Limited Vitamin D3 derivatives, process for preparation thereof, and antigens comprising said derivatives to be used for preparation of antibodies for immunochemical assay and antibodies prepared therefrom
JPH02274A (ja) 1987-10-14 1990-01-05 Toyo Jozo Co Ltd 新規な２５−ヒドロキシビタミンｄ↓３誘導体およびその製造法およびそれを用いた定量法
FR2631025B1 (fr) 1988-05-04 1991-04-12 Ire Medgenix Sa Nouveaux derives de la vitamine d3 et application aux dosages des metabolites de la vitamine d3
GB9325415D0 (en) 1993-12-13 1994-02-16 Res Inst Medicine Chem Chemical compounds
US5821020A (en) 1995-07-14 1998-10-13 Nhh Biologics Vitamin D assay
CN1254293A (zh) 1997-02-13 2000-05-24 骨疗国际公司 靶向治疗性给药维生素d化合物
EP1073464B1 (en) 1998-04-28 2004-10-06 Smithkline Beecham Corporation Monoclonal antibodies with reduced immunogenicity
DE19981132D2 (de) 1998-06-25 2001-10-18 Immundiagnostik Ges Fuer Produ Funktionelle Vitamin-D-Derivate und Verfahren zur Bestimmung von 25-Hydroxy- und 1alpha,25-Dihydroxy-Vitamin-D
JP3589912B2 (ja) 1999-09-03 2004-11-17 泰久 福井 ホスファチジルイノシトール−３，４−二リン酸を認識するモノクローナル抗体
GB0029729D0 (en) * 2000-12-06 2001-01-17 Ids Ltd Method for detection of vitamin D metabolites
US7087395B1 (en) 2001-01-16 2006-08-08 Quest Diagnostics Investments Incorporated Vitamin D assay
US7630836B2 (en) 2001-05-30 2009-12-08 The Kitasato Institute Polynucleotides
USH2220H1 (en) 2001-08-10 2008-07-01 Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
US20040142325A1 (en) 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
EP1612224B1 (en) 2004-06-29 2012-03-07 B.R.A.H.M.S GmbH Novel monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
US20080148432A1 (en) 2005-12-21 2008-06-19 Mark Scott Abad Transgenic plants with enhanced agronomic traits
JP4852614B2 (ja) 2005-09-29 2012-01-11 エフ．ホフマン−ラ ロシュ アーゲー ビタミンｄ化合物のための放出試薬
EP1999153B1 (en) 2006-03-29 2014-04-23 King's College London Agonist antibodies against tshr
ATE452343T1 (de) 2006-06-06 2010-01-15 Hoffmann La Roche Verbesserte vitamin-d-messung
US20080148421A1 (en) 2006-12-14 2008-06-19 Monsanto Technology Llc Plants and seeds of corn variety lh361
DE602008001667D1 (de) 2007-02-01 2010-08-12 Immundiagnostik Ag Direktbestimmung von vitamin d im serum oder plasma
EP2233501B1 (en) 2007-12-13 2012-07-11 Shanghai Guojian Bio-Tech Institute Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof
CA2714413C (en) 2008-02-08 2017-01-24 Immunas Pharma, Inc. Antibody capable of binding specifically to ab-oligomer, and use thereof
US20110212534A1 (en) 2008-08-11 2011-09-01 Taylor Robert L Methods for determining levels of 1,25 dihydroxy vitamin d2 and d3
EP2488867B1 (en) 2009-10-14 2020-09-30 Janssen Biotech, Inc. Methods of affinity maturing antibodies
UA106771C2 (uk) 2009-10-16 2014-10-10 Ле Лаборатуар Сервьє Моноклональні антитіла до прогастрину та їх використання
US8785603B2 (en) * 2011-05-20 2014-07-22 Siemens Healthcare Diagnostics Inc. Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009509992A (ja) * 2005-09-29 2009-03-12 エフ．ホフマン−ラ ロシュ アーゲー ２５−ヒドロキシビタミンｄに対する抗体
US20110097733A1 (en) * 2009-10-27 2011-04-28 Michel Anciaux Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6016012103; Ｃｌｉｎ．　Ｃｈｅｍ． ｖｏｌ．３１，　ｎｏ．１１, 1985, ｐｐ．１８１５-１８１９ *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022020884A (ja) * 2020-07-21 2022-02-02 株式会社ファンケル 血清ビタミンｄ代謝物の濃度の推定方法
JP7413624B2 (ja) 2020-07-21 2024-01-16 株式会社ファンケル 血清ビタミンｄ代謝物の濃度の推定方法
JP2024535594A (ja) * 2021-10-13 2024-09-30 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド Ｄｈｅａｓアッセイ、そのための試薬、並びにその製造方法及び使用

Also Published As

Publication number Publication date
US20180372761A1 (en) 2018-12-27
JP2017040659A (ja) 2017-02-23
US20140336156A1 (en) 2014-11-13
CN103857698A (zh) 2014-06-11
US12379386B2 (en) 2025-08-05
EP2710376A2 (en) 2014-03-26
KR102032531B1 (ko) 2019-11-28
US8785603B2 (en) 2014-07-22
EP2710376A4 (en) 2015-04-15
AU2012259080A1 (en) 2013-10-31
US20130059825A1 (en) 2013-03-07
KR20140086925A (ko) 2014-07-08
US11815517B2 (en) 2023-11-14
EP2710376B1 (en) 2018-11-14
AU2017203779B2 (en) 2019-08-01
AU2017203779A1 (en) 2017-06-22
WO2012162165A2 (en) 2012-11-29
US10837973B2 (en) 2020-11-17
WO2012162165A3 (en) 2013-01-17
US20240094227A1 (en) 2024-03-21
ES2710449T3 (es) 2019-04-25
US20210055314A1 (en) 2021-02-25
US20250110139A1 (en) 2025-04-03
JP6404876B2 (ja) 2018-10-17
CN103857698B (zh) 2016-09-21

Similar Documents

Publication Publication Date Title
US12379386B2 (en) Antibodies to 25-hydroxyvitamin D2 and D3 for detecting total 25-hydroxyvitamin D
CN105624118B (zh) 非交叉反应性抗IgG抗体
CN104955841B (zh) 用于检测1,25-二羟基维生素d的方法和试剂盒以及相关抗体
US8283162B2 (en) Antibodies relating to PIVKAII and uses thereof
EP2638071A1 (en) Hydroxycholesterol immunoassay
US11372001B2 (en) Anti-human IgG4 monoclonal antibody and methods of making and using same
EP2754672B1 (en) Antibody capable of binding to specific region of periostin, and method of measuring periostin using the same
KR101566090B1 (ko) 항―인간 ＩｇＧ１ 항체
WO2009116268A1 (ja) 可溶性ｌｒ１１の定量方法
US20140243265A1 (en) Antibodies to modified human igf-1/e peptides
JP2020510841A (ja) ヒトエリスロフェロン抗体及びその使用
JP7475584B2 (ja) 免疫グロブリンａに結合しているペリオスチン並びに免疫グロブリンａに結合しているペリオスチンに結合する抗体、ペリオスチンの測定方法、ペリオスチンの測定試薬及びペリオスチン測定の正確性の改善方法
JP2011160696A (ja) 修飾ヒトｉｇｆ−１／ｅペプチドに対する抗体
CN114106163A (zh) SARS-CoV-2病毒中和抗体及其用途
JP2018080167A (ja) 肝性リパーゼに対する抗体及びその利用
BR112017008985B1 (pt) Método in vitro para a determinação da concentração de 25-hidroxivitamina d, uso de um método in vitro, uso de um primeiro agente de ligação e kit

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20140404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140404

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150518

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150518

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160324

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160329

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160616

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160815

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20161122